Hence, we explored the therapeutic potential of targeting ATP receptors in epilepsy treatment, with a specific interest on TNP-ATP, a purinergic receptor antagonist, in a mouse model of mesial temporal lobe epilepsy. The gene discussed is P2RX1; the disease is epilepsy.